DXB 0.00% 38.0¢ dimerix limited

Dimerix's Kathy Harrison discusses pending Phase 2 clinical trials, page-14

  1. 306 Posts.
    lightbulb Created with Sketch. 16
    Nice work, I'll be watching with interest for the results of the trial
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.